New perspectives for hepatitis B vaccines and immunization

Vaccine

Volumn 27, Issue 25-26, 2009, Pages 3271-3275

  Rapicetta, Maria ^a   D'Ugo, Emilio ^a   Argentini, Claudio ^a   Catone, Stefania ^a   Canitano, Andrea ^a   Giuseppetti, Roberto ^a   Gluck, Reinhard ^b  

^a Viral Hepatitis Unit   (Italy)

^b Berna Biotech AG   (Switzerland)

Author keywords

HBV infection; HBV vaccine; Immunotherapy; WHV; Woodchuck

Indexed keywords

HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; LAMIVUDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; IMMUNOMODULATION; INFECTION; NONHUMAN; PRIORITY JOURNAL; SCIURIDAE; VIRUS REPLICATION; WOODCHUCK;

ANIMALS; DNA, VIRAL; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; IMMUNIZATION; LAMIVUDINE; MARMOTA; VACCINES, SYNTHETIC; VIRAL LOAD;

EID: 67349143378     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.01.063     Document Type: Article

References (9)

1. Keeffe E.B. Acute hepatitis A and B in patients with chronic liver disease: prevention through vaccination. Am J Med 118 10 (2005) 21S-27S
2. Chow K.M., Lau M.C., Leung C.B., Szeto C.C., and Li P.K.T. Antibody response to hepatitis B vaccine in end-stage renal disease patients. Nephron Clin Pract 103 (2006) c89-c93
3. Hunt C.M., McGill J.M., Allen M.I., and Condreay L.D. Clinical relevance of hepatitis B viral mutations. Hepatology 31 5 (2000) 1037-1044
4. Berzofsky J.A., Ahlers J.D., and Belyakov I.M. Strategies for designing and optimizing new generation vaccines. Nat Rev 1 (2001) 209-219
5. Menne S., and Cote P.J. The woodchuck as an animal model for pathogenesis and therapy of chronic hepatitis B virus infection. World J Gastroenterol 13 1 (2007) 104-124
6. La Sorsa V., Argentini C., Bruni R., Villano U., Giuseppetti R., and Rapicetta M. In vivo transmission and dynamics of deleted genomes after experimental infection of woodchuck hepatitis B virus in adult animals. Virus Genes 25 (2002) 147-157
7. D'Ugo E., Kondili L.A., Canitano A., Catone S., Giuseppetti R., Gallinella B., et al. Rapid emergence of a viral resistant mutant in WHV chronically infected woodchucks treated with lamivudine and a pre-S/S CHO-derived hepatitis B virus vaccine. Vaccine 25 (2007) 4895-4902
8. Yao X., Zheng B., Zhou J., Dao-Zhen X., Zhao K., Shu-Hui S., et al. Therapeutic effect of hepatitis B surface antigen-antibody complex is associated with cytolytic and non-cytolytic immune responses in hepatitis B patients. Vaccine 25 10 (2007) 1771-1779
9. Roggendorf M., Schulte I., Xu Y., and Lu M. Therapeutic vaccination in chronic hepatitis B: preclinical studies in the woodchuck model. J Viral Hep 14 Suppl. 1 (2007) 51-57